Liberty Ridge Advisors Announces the Sale of Microbiological Testing Products Company, BioMed Diagnostics to DCN Dx
FOR IMMEDIATE RELEASE
CARLSBAD, CA—April 27th, 2022—DCN Dx, a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests, has completed a West Coast acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, OR. The deal Expands DCN Dx’s footprint in the point-of-use testing and sampling market in both human and veterinary verticals. Liberty Ridge Advisors served as the exclusive financial advisor to BioMed.
Biomed has an established history of developing tools for the surveillance of microorganisms that lead to infectious diseases in humans and animals. Originally developed for use in low-resource settings, these tools are now recognized around the world for their utility, ease of use, and accuracy.
“Biomed has a strong presence in microbiological testing for veterinary, human, food safety and environmental markets, and has developed innovative solutions that combine specimen collection, culture and transport in a single device,” said Charlie Mamrak, DCN Dx’s CEO. “The portfolio of novel testing and sampling products is a perfect adjacency for DCN Dx’s core business of point-of-use test development. We’re excited to integrate Biomed’s capabilities into our own as we provide world-class solutions to our clients.”
Biomed’s CEO, Amir Kanji said, “I found Liberty Ridge Advisors excellent to work with; they were great at diligently communicating with me and problem-solving throughout our complex international sales process, which I found impressive. I certainly would refer them to peers.”
New Products
Biomed brings a number of products to DCN Dx’s stable, including:
InPouch TF®, a simple-to-use culture media for the detection of the parasite that causes bovine trichomoniasis
TF Transit Tube, a self-contained system for the collection and transport of Tritrichomonas foetus from bovine preputial or vaginal samples
InPouch® TV, a self-contained broth media device for the recovery and detection of Trichnomonas vaginalis from human female vaginal samples or male urethra/urine samples
Transport Media (VTM) for SARS-CoV-2 sample transport
The INTRAY VS COLOREXTM product line for convenient testing for microbes including MRSA and other resistant bacteria
About DCN Dx
DCN Dx is a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests. Founded in 2005 from its headquarters in Southern California, DCN Dx’s cross-functional team of scientists and engineers develop and integrate all aspects of assays into reliable systems for point-of-use applications that enable users to monitor sample quality, identify pathogens, and facilitate the delivery of treatments. DCN Dx partners with industry leaders to develop point-of-use tests, train users in diagnostic development, and carry out clinical research for medical point-of-care testing, veterinary diagnostics, soil and water testing, bioprocessing, food safety, force protection, and more. For more information, visit dcndx.com.
About BioMed Diagnostics
BioMed Diagnostics was founded in 1989 and develops diagnostic devices and packaging/transport devices for microbiology and molecular testing. The Company has developed and patented proprietary products regarded as unique in the market. BioMed’s products support easy sample collection at the point of care, low-cost microbiology-based diagnostics, and sample transport to central labs for molecular testing. For more information, visit biomeddiagnostics.com.
For more information about this transaction, please contact the Liberty Ridge Advisors deal team:
Michael Bennett Leif Johnson
Managing Partner Managing Partner
mbennett@libertyra.com ljohnson@libertyra.com
About Liberty Ridge Advisors
Liberty Ridge Advisors provides Pacific Northwest privately held businesses' merger and acquisition advisory services, including capital transactions, mergers, acquisitions, and recapitalizations. Liberty Ridge Advisors offers concentrated experience and expertise in key industries such as aerospace, building materials, specialty contractors, medical products, general manufacturing, and distribution, applied technology, wine, business and financial services, agricultural and food products. For more information about Liberty Ridge Advisors, please visit our website at libertyra.com.
###
Investment Banking Services and Securities offered through Independent Investment Bankers Corp. a broker-dealer, Member FINRA/SIPC. Liberty Ridge Advisors, LLC is not affiliated with Independent Investment Bankers Corp
Contact:
Michael Bennett, Managing Partner, Liberty Ridge Advisors, LLC
Email: mbennett@libertyra.com
Phone: (206) 422-0102